Rahul Ballal
Director/Board Member at AGIOS PHARMACEUTICALS, INC.
Net worth: 460 289 $ as of 2024-03-30
Profile
Rahul D.
Ballal is the founder.
He founded TSS Redmond LLC in 2002 and served as the Chief Executive Officer.
Dr. Ballal is also the founder of Redmind LLC.
Dr. Ballal's current job(s) include being the Chief Executive Officer at Mediar Therapeutics, Inc., an Independent Director at Agios Pharmaceuticals, Inc., a Director at Enliven Therapeutics, Inc., and a Director at Vaderis Therapeutics AG.
Dr. Ballal's former job(s) include being the President, Chief Executive Officer & Director at Imara, Inc., Vice President-Business Development at Flexion Therapeutics, Inc., an Entrepreneur in Residence at Versant Venture Management LLC, and Chief Business Officer at Northern Biologics, Inc.Dr. Ballal's education history includes an undergraduate degree from Brown University, a graduate degree from The Johns Hopkins University, and a doctorate degree from Georgetown University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-04-10 | 22,341 ( 0.05% ) | 392 978 $ | 2024-03-30 | |
| 2023-08-10 | 2,302 ( 0.00% ) | 67 310 $ | 2024-03-30 |
Rahul Ballal active positions
| Companies | Position | Start |
|---|---|---|
| AGIOS PHARMACEUTICALS, INC. | Director/Board Member | 2022-08-10 |
| ENLIVEN THERAPEUTICS, INC. | Director/Board Member | 2023-02-22 |
Mediar Therapeutics, Inc.
 Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Chief Executive Officer | - |
Vaderis Therapeutics AG
 Vaderis Therapeutics AG BiotechnologyHealth Technology Vaderis Therapeutics AG is a clinical stage biotech company based in Basel, Switzerland. The Swiss company aims to develop medicinal treatments for rare and orphan diseases associated with vascular malformations. The company focuses on developing a medicine for the treatment of HHT and other diseases associated with vascular malformations. HHT is a rare disease that causes vascular overgrowth due to genetic mutations, and there are no drugs approved anywhere in the world that specifically treat it. The company was founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard, and Nicholas Benedict has been the CEO since incorporation. Vaderis raised a series a financing from Medicxi and acquired a portfolio of allosteric Akt inhibitors from Almac Discovery Ltd. | Director/Board Member | - |
Former positions of Rahul Ballal
| Companies | Position | End |
|---|---|---|
Northern Biologics, Inc.
 Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Corporate Officer/Principal | 2018-05-31 |
| FLEXION THERAPEUTICS, INC. | Corporate Officer/Principal | 2016-04-30 |
TSS Redmond LLC
 TSS Redmond LLC Packaged SoftwareTechnology Services TSS Redmond LLC provides end-to-end share point, desktop and office 365 solutions. The firm is a one-stop training organization, offering clients the convenience of training in Microsoft content and testing for a credential all at one facility and with its testing center, TSS serves the Microsoft community with both prometric and certiport facilities. The company is headquartered in Redmond, WA. | Chief Executive Officer | 2002-05-31 |
| Redmind LLC | Chief Executive Officer | - |
| IMARA | Chief Executive Officer | - |
Training of Rahul Ballal
| Brown University | Undergraduate Degree |
| The Johns Hopkins University | Graduate Degree |
| Georgetown University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| AGIOS PHARMACEUTICALS, INC. | Health Technology |
| ENLIVEN THERAPEUTICS, INC. | Health Technology |
| Private companies | 8 |
|---|---|
Flexion Therapeutics, Inc.
 Flexion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Flexion Therapeutics, Inc. operates as a biopharmaceutical company, which engages in the development and commercialization of novel and local therapies. It specializes in the treatment of patients with musculoskeletal conditions including osteoarthritis. It offers products under the Zilretta brand, an extended-release corticosteroid approved to manage osteoarthritis knee pain. The company was founded by Michael D. Clayman and Neil Bodick on November 5, 2007 and is headquartered in Burlington, MA. | Health Technology |
Versant Venture Management LLC
 Versant Venture Management LLC Investment ManagersFinance Versant Venture Management LLC (Versant Ventures) is an independent venture capital firm founded in 1999 by Brian Atwood, Samuel Colella, Bill Link and Ross Jaffe. The firm is headquartered in San Francisco with additional offices in Basel and Vancouver. | Finance |
TSS Redmond LLC
TSS Redmond LLC Packaged SoftwareTechnology Services TSS Redmond LLC provides end-to-end share point, desktop and office 365 solutions. The firm is a one-stop training organization, offering clients the convenience of training in Microsoft content and testing for a credential all at one facility and with its testing center, TSS serves the Microsoft community with both prometric and certiport facilities. The company is headquartered in Redmond, WA. | Technology Services |
Northern Biologics, Inc.
Northern Biologics, Inc. Hospital/Nursing ManagementHealth Services Northern Biologics Inc. operates as an early-stage biologics company. It develops a portfolio of antibody-based therapeutics for oncology and fibrosis. The company was founded by Jason Moffat, Rob Rottapel, Benjamin G. Neel, Sachdev Sidhu, Brad Wouters, and Stefan Larson in June 2014 and is headquartered in Toronto, Canada. | Health Services |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Mediar Therapeutics, Inc.
Mediar Therapeutics, Inc. BiotechnologyHealth Technology Mediar Therapeutics, Inc. develops therapeutics to halt, reverse and fibrosis. The company was founded by Paul Yaworsky in 2018 and is headquartered in Cambridge, MA. | Health Technology |
Vaderis Therapeutics AG
Vaderis Therapeutics AG BiotechnologyHealth Technology Vaderis Therapeutics AG is a clinical stage biotech company based in Basel, Switzerland. The Swiss company aims to develop medicinal treatments for rare and orphan diseases associated with vascular malformations. The company focuses on developing a medicine for the treatment of HHT and other diseases associated with vascular malformations. HHT is a rare disease that causes vascular overgrowth due to genetic mutations, and there are no drugs approved anywhere in the world that specifically treat it. The company was founded in 2019 by Nicholas Benedict, Pierre Saint-Mezard, and Damien Picard, and Nicholas Benedict has been the CEO since incorporation. Vaderis raised a series a financing from Medicxi and acquired a portfolio of allosteric Akt inhibitors from Almac Discovery Ltd. | Health Technology |
| Redmind LLC |
- Stock Market
- Insiders
- Rahul Ballal